Skip to main content

Advertisement

Table 1 Clinicopathologic characteristics (N = 29)

From: Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment

  patients, n (%) Subtype I Subtype II p value
Age (year)
 Mean 56 54 60  
 Range 35–73 35–73 41–71  
Race
 White 20 14 6  
 Black or African American 4 2 2  
 Asian 1 1 0  
 Unknown 4 3 1  
Tumor weight     0.4
 Mean 341.83 303.8 426.33  
 Range 55–1100 58–1100 55–1077  
Treatment best response     0.04
 Complete Response 8(27%) 6 2  
 Partial Response 2(7%) 0 2  
 Clinical Progressive Disease 4(14%) 4 0  
 Unknown 15(52%) 10 5  
Metastatic disease confirmed     0.18
 YES 10 (34%) 5 5  
 NO 11 (38%) 9 2  
 Unknown 8 (28%) 6 2  
Contiguous organ invaded     0.24
 YES 4(14%) 2 2  
 NO 8 (28%) 7 1  
 Unknown 17 (58%) 11 6  
Necrosis percent     0.52
 Mean 20.33 23.5 14  
 Range 0–50 1–50 0–33  
  1. * p < 0.05